02.24.25 -- How To Best Optimize mRNA Production Workflows

Unlock automated, precise biomolecular structure measurements from a single drop. Gain cleaner, faster, more critical insights into your biomolecules with this innovative solution.

Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

The TakeOne is a single-use, pre-assembled sampling device for aseptic collection of samples during upstream and downstream process steps. It is ideal for critical endotoxin, bioburden, sterility and purity checks.

Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

Multiple steps in the mRNA manufacturing process can appear more complex than they have to be. Learn how to simplify your approach and produce the best possible mRNA vaccines and therapeutics.

Design your mRNA manufacturing process with the certainty of fit-for-purpose standards for raw materials.

Trust an experienced and trustworthy partner who understands the varying challenges you face and helps you solve them efficiently, safely and speedily.

Seamlessly transition from discovery to delivery with INDe sgRNAs. These quality sgRNAs can be synthesized in quantities from milligrams to grams and follow high purity specifications.

Synthesize oligonucleotides at scales of 10–100 mmol for early to mid-phase clinical trials or for diagnostic kits.

Uncover how environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Gain insight into how you can de-risk mRNA regulatory approvals with critical quality attribute characterization and lot release testing.

Discover innovative approaches to oligonucleotide synthesis, showcasing their superior performance compared to traditional liquid chromatography methods.

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

Accelerate your drug discovery and development process by leveraging comprehensive quality insights for faster and more effective results.